LOSA, MARCO
 Distribuzione geografica
Continente #
AS - Asia 3.377
NA - Nord America 2.172
EU - Europa 1.441
SA - Sud America 864
AF - Africa 58
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.923
Nazione #
US - Stati Uniti d'America 2.070
SG - Singapore 1.432
CN - Cina 975
BR - Brasile 742
HK - Hong Kong 495
SE - Svezia 495
IT - Italia 267
VN - Vietnam 213
RU - Federazione Russa 199
DE - Germania 121
GB - Regno Unito 82
IE - Irlanda 68
IN - India 65
AR - Argentina 57
CA - Canada 44
MX - Messico 42
AT - Austria 34
BD - Bangladesh 34
PL - Polonia 33
FI - Finlandia 30
FR - Francia 27
JP - Giappone 25
ID - Indonesia 24
ZA - Sudafrica 20
NL - Olanda 19
TR - Turchia 18
EC - Ecuador 17
EG - Egitto 17
ES - Italia 14
IQ - Iraq 12
MA - Marocco 11
VE - Venezuela 11
LT - Lituania 10
PY - Paraguay 10
UA - Ucraina 10
CL - Cile 8
CO - Colombia 8
PK - Pakistan 8
UZ - Uzbekistan 8
AU - Australia 7
KZ - Kazakistan 7
IR - Iran 6
PE - Perù 6
PH - Filippine 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
SA - Arabia Saudita 5
DO - Repubblica Dominicana 4
IL - Israele 4
UY - Uruguay 4
CH - Svizzera 3
CZ - Repubblica Ceca 3
GR - Grecia 3
HU - Ungheria 3
LB - Libano 3
MY - Malesia 3
NO - Norvegia 3
TH - Thailandia 3
TN - Tunisia 3
BA - Bosnia-Erzegovina 2
BE - Belgio 2
BH - Bahrain 2
CR - Costa Rica 2
ET - Etiopia 2
JM - Giamaica 2
JO - Giordania 2
KG - Kirghizistan 2
LV - Lettonia 2
NG - Nigeria 2
NI - Nicaragua 2
NP - Nepal 2
PA - Panama 2
PS - Palestinian Territory 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DZ - Algeria 1
GD - Grenada 1
GE - Georgia 1
IS - Islanda 1
KE - Kenya 1
KR - Corea 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
MK - Macedonia 1
MN - Mongolia 1
MT - Malta 1
OM - Oman 1
PT - Portogallo 1
PW - Palau 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
Totale 7.920
Città #
Singapore 614
Hong Kong 493
Dallas 374
Ashburn 297
Shanghai 267
Hefei 202
Lawrence 168
Princeton 168
Beijing 121
New York 105
Moscow 103
Milan 83
Ho Chi Minh City 76
São Paulo 71
Dublin 68
Los Angeles 62
North Charleston 61
Council Bluffs 50
Munich 50
Hanoi 46
Las Vegas 40
Warsaw 30
Rome 29
Boardman 25
Tokyo 25
The Dalles 24
Waynesboro 24
Rio de Janeiro 23
Seattle 23
Nuremberg 22
Chennai 21
Santa Clara 19
Washington 19
Boston 17
Haiphong 17
London 17
Brooklyn 16
Curitiba 16
Manchester 16
Orem 16
Poplar 16
Belo Horizonte 15
Chicago 15
Helsinki 15
Guangzhou 14
Montreal 14
Phoenix 14
Stockholm 14
Toronto 14
Turku 14
Atlanta 13
Brasília 13
Cairo 13
Vienna 13
Frankfurt am Main 12
Houston 12
Pune 12
Campinas 11
Columbus 11
Denver 11
Mexico City 11
Porto Alegre 10
San Francisco 10
Amsterdam 9
Cesano Boscone 9
Johannesburg 9
Querétaro 9
Charlottesville 8
Guarulhos 8
Shenzhen 8
Ankara 7
Bologna 7
Casablanca 7
Contagem 7
Hanover 7
Hải Dương 7
Ribeirão Preto 7
Salvador 7
Tashkent 7
Dhaka 6
Guayaquil 6
Miami 6
Asunción 5
Buenos Aires 5
Caracas 5
Goiânia 5
Hangzhou 5
Jundiaí 5
Lima 5
Naples 5
Osasco 5
Paris 5
Pozza di Fassa 5
Quito 5
Shijiazhuang 5
Suzano 5
São Bernardo do Campo 5
Thái Bình 5
Tianjin 5
Bauru 4
Totale 4.445
Nome #
Cushing's disease due to double pituitary ACTH-secreting adenomas: The first case report 247
Pituitary Surgery 131
A consensus on the diagnosis and treatment of acromegaly comorbidities: An update 88
Acromegaly associated with a granular cell tumor of the neurohypophysis: a clinical and histological study - Case report 87
Asymptomatic Thyrotropin-secreting Pituitary Macroadenoma in a Thirteen Year-old Girl: Successful First-line Treatment with Somatostatin Analogues 83
A non-functioning pituitary adenoma initially mimicking a microprolactinoma: The case for long-term follow-up of patients with mild hyperprolactinemia? 77
Analysis of somatostatin receptors 2 and 5 polymorphisms in patients with acromegaly 76
Craniopharyngioma 74
High Prevalence of Vertebral Fractures Associated With Preoperative GH Levels in Patients With Recent Diagnosis of Acromegaly 71
Novel approach to bone comorbidity in resistant acromegaly 71
Acromegaly: surgical results and prognosis. 69
Long-course temozolomide in aggressive pituitary adenoma: real-life experience in two tertiary care centers and review of the literature 69
Bacterial endotoxin (Lipopolysaccharide) stimulates interleukin-6 production and inhibits growth of pituitary tumour cells expressing the Toll-like receptor 4 68
A Multicenter, Propensity Score–Matched Assessment of Endoscopic Versus Microscopic Approaches in the Management of Pituitary Adenomas 67
Normal insulin-like growth factor 1 during somatostatin receptor ligand treatment predicts surgical cure in acromegaly 66
Gamma knife radiosurgery in patients with Nelson’s syndrome 66
Gamma knife radiosurgery for pituitary tumors: A systematic review and meta‐analysis 66
Acromegaly is associated with increased cancer risk: A survey in Italy 65
High prevalence of adrenal cortical adenomas in patients with cerebral meningiomas 64
Benign and Malignant Tumors of the Pituitary Gland 64
Craniopharyngiomas 62
The optimal numerosity of the referral population of pituitary tumors centers of excellence (PTCOE): A surgical perspective 61
AZA-Deoxycytidine stimulates proopiomelanocortin gene expression and ACTH secretion in human pituitary ACTH-secreting tumors 60
Comparison between extended transsphenoidal and transcranial surgery for craniopharyngioma: focus on hypothalamic function and obesity 57
High prevalence of morphometric vertebral fractures opportunistically detected on thoracic radiograms in patients with non-functioning pituitary adenoma 56
The open sella technique for surgical treatment of pituitary macroadenomas: Safety and efficacy in a large clinical series 56
A conformational switch controlling the toxicity of the prion protein 55
Widened transnasal surgical approach for removal of huge, forward-spreading pituitary neoplasms 55
Primary sellar melanocytoma: report of two cases treated at the same institution and their long-term outcome 55
Pituitary radiotherapy for Cushing's disease 54
Bone morphogenetic protein-4 inhibits corticotroph tumor cells: Involvement in the retinoic acid inhibitory action 53
Bone and body composition analyses by DXA in adults with GH deficiency: effects of long-term replacement therapy 53
Intranasal oxytocin as a treatment for obesity: safety and efficacy 52
Analysis of characteristics and outcomes by growth hormone treatment duration in adult patients in the Italian cohort of the Hypopituitary Control and Complications Study (HypoCCS) 52
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study 52
Bilateral inferior petrosal sinus sampling in adrenocorticotropin-dependent hypercortisolism: always, never, or sometimes? 51
Dosimetric factors associated with pituitary function after Gamma Knife Surgery (GKS) of pituitary adenomas. 50
Craniopharyngioma in Pediatrics and Adults 49
Solitary clival plasmocytomas: Misleading clinical and radiological features of a rare pathology with a specific biological behaviour. 49
Erratum: Time course of hypothalamic-pituitary deficiency in adults receiving cranial radiotherapy for primary extrasellar brain tumors (Radiotherapy and Oncology 99 (2011) (23-28)) 48
Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients 47
Asymptomatic internal carotid artery occlusion after gamma knife radiosurgery for pituitary adenoma: Report of two cases and review of the literature 47
Surgical approach to craniopharyngiomas: transcranial routes 47
D3-Growth hormone receptor polymorphism in acromegaly: Effects on metabolic phenotype 46
Resistance to first-generation somatostatin receptor ligands does not impair the results of gamma knife radiosurgery in acromegaly 46
Complications of transsphenoidal surgery in patients with pituitary adenoma: experience at a single centre 45
Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: experience in six cases. 45
Ubiquitin-Specific Protease 8 Mutant Corticotrope Adenomas Present Unique Secretory and Molecular Features and Shed Light on the Role of Ubiquitylation on ACTH Processing 45
Bilateral inferior petrosal sinus sampling with human CRH stimulation in ACTH-dependent Cushing's syndrome: results from a retrospective multicenter study 44
Desmopressin stimulation test before and after pituitary surgery in patients with Cushing's disease 44
Role of radiosurgery in the treatment of Cushing's disease 43
Coexistence of TSH-secreting pituitary adenoma and autoimmune hypothyroidism 43
Metastatic prostatic adenocarcinoma presenting as a pituitary mass: Shrinkage of the lesion and clinical improvement with medical treatment 43
Combined insulin resistance of glucose and protein metabolism in acromegaly 43
IL-23 secreted by myeloid cells drives castration-resistant prostate cancer 43
Italian Association of Clinical Endocrinologists (AME) and International Chapter of Clinical Endocrinology (ICCE). Position statement for clinical practice: prolactin-secreting tumors 42
Longitudinal splitting of optic pathways by non-functioning pituitary macroadenoma: report of two cases. 42
Loss of heterozygosity at the SS receptor type 5 locus in human GH- and TSH-secreting pituitary adenomas 42
Repeat gamma knife radiosurgery for recurrent pituitary adenomas. 41
Hypokalemic periodic paralysis in a patient with acquired growth hormone deficiency 41
Criteria of cure and follow-up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas RID B-6543-2008 41
Predictors of morbidity and mortality in acromegaly: An Italian survey 41
Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS) 41
Differential expression of menin in sporadic pituitary adenomas 41
Clinical characteristics and surgical outcome in USP8-mutated human adrenocorticotropic hormone-secreting pituitary adenomas 41
Time to Diagnosis in Cushing's Syndrome: A Meta-Analysis Based on 5367 Patients 41
Crooke Cell Adenoma Confers Poorer Endocrinological Outcomes Compared with Corticotroph Adenoma: Results of a Multicenter, International Analysis 40
Thyrotropin-secreting pituitary adenomas: biological and molecular features, diagnosis and therapy 40
Metallothionein 1G acts as an oncosupressor in papillary thyroid carcinoma 40
Pros and cons in endocrine practice: pre-surgical treatment with somatostatin analogues in acromegaly 40
Microsurgical therapy of pituitary adenomas 40
Non-functioning pituitary adenoma database: A useful resource to improve the clinical management of pituitary tumors 40
High prevalence of radiological vertebral fractures inpatients With TSH-secreting pituitary adenoma 40
Letter to the Editor. Management of residual nonfunctioning pituitary adenoma: watchful waiting or adjuvant treatment? 39
Indium-111 pentetreotide single-photon emission tomography in patients with TSH-secreting pituitary adenomas: correlation with the effect of a single administration of octreotide on serum TSH levels RID B-6543-2008 39
Effects of octreotide treatment on the proliferation and apoptotic index of GH-secreting pituitary adenomas 39
Differentiation of clinically non-functioning pituitary adenomas from meningiomas and craniopharyngiomas by positron emission tomography with [F-18]fluoro-ethyl-spiperone RID C-6773-2008 39
Surgical treatment of prolactin-secreting pituitary adenomas: Early results and long-term outcome 39
Treatment of empty sella associated with visual impairment: a systematic review of chiasmapexy techniques 39
Lymphocytic hypophysitis: Differential diagnosis and effects of high-dose pulse steroids, followed by azathioprine, on the pituitary mass and endocrine abnormalities - Report of a case and literature review 39
Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement 39
Primary sellar melanocytoma: pathological, clinical and treatment review 39
Corticotroph tumor progression after bilateral adrenalectomy (Nelson’s syndrome): systematic review and expert consensus recommendations 39
The High Mobility Group A2 gene is amplified and overexpressed in human prolactinomas 38
Magnetic resonance imaging as predictor of functional outcome in craniopharyngiomas 38
Intrasellar paraganglioma: a case report and review of the literature 38
First-line therapy of acromegaly: A statement of the A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous Medical Education) Study Group 38
Safety and efficacy of multisession gamma knife radiosurgery for residual or recurrent pituitary adenomas 38
The role of surgical management for prolactin-secreting tumors in the era of dopaminergic agonists: An international multicenter report 37
Combined characterization of a pituitary adenoma and a subcutaneous lipoma in a MEN1 patient with a whole gene deletion 37
High-mobility group A2 gene expression is frequently induced in non-functioning pituitary adenomas (NFPAs), even in the absence of chromosome 12 polysomy 37
Radiotherapy of Parasellar Tumours 37
Proliferation index of nonfunctioning pituitary adenomas: Correlations with clinical characteristics and long-term follow-up results 36
Results of Gamma Knife Radiosurgery in Acromegaly 36
La terapia chirurgica dell'acromegalia 36
Single fraction and multisession Gamma Knife radiosurgery for craniopharyngioma 36
Treatment of aggressive pituitary tumours and carcinomas: Results of a European Society of Endocrinology (ESE) survey 2016 36
Short-term evaluation of cardiac morphology, function, metabolism and structure following diagnosis of adult-onset growth hormone deficiency 36
Gamma knife surgery for treatment of residual nonfunctioning pituitary adenomas after surgical debulking 36
Growth hormone therapy does not increase the risk of craniopharyngioma and nonfunctioning pituitary adenoma recurrence 36
Totale 5.170
Categoria #
all - tutte 69.063
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.063


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202159 0 0 0 0 0 28 29 1 0 1 0 0
2021/202286 0 0 0 49 7 1 13 3 1 2 1 9
2022/2023939 364 169 87 39 10 100 70 74 20 2 1 3
2023/2024491 18 5 40 37 46 140 6 39 3 17 26 114
2024/20252.492 359 62 15 77 68 234 371 163 418 312 187 226
2025/20263.987 602 786 734 1.122 557 186 0 0 0 0 0 0
Totale 8.163